Skip to content
YCS24· AI

Evolvere BioSciences

Making Next-Generation Antibiotics that Outpace Bacterial Evolution

ActiveChecked 17h ago
Batch
S24
Status, per YC
Active
Team size
3
HQ
Oxford, England
In S24248 companies, 85% AI

Founders

  • Adam WinnifrithFounder/CEO
  • Piotr JedryszekFounder/CTO
  • Weronika SlesakFounder

Same space

About Evolvere BioSciences

🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells. ☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - already killing more people than malaria and AIDS and it is getting exponentially worse 📈. 🧬 Our approach leverages co-evolutionary protein-protein interaction datasets combined with AI to forecast bacterial mutations and create ‘future-proof’ antibiotics, addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat patients 👩‍⚕️. We are a team of biochemists and evolutionary biologists who met at the University of Oxford.

Oxford, England, United Kingdom

Evolvere BioSciences: questions

Which YC batch was Evolvere BioSciences in?

Evolvere BioSciences was in Y Combinator's Summer 2024 batch (S24).

Is Evolvere BioSciences still active?

Y Combinator lists Evolvere BioSciences as active.

Who founded Evolvere BioSciences?

Evolvere BioSciences's founders, as listed on its YC page: Adam Winnifrith (Founder/CEO), Piotr Jedryszek (Founder/CTO), Weronika Slesak (Founder).

Where is Evolvere BioSciences based?

Evolvere BioSciences lists Oxford, England, United Kingdom as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.

Weekly: new YC data, AI and devtools companies and status changes, Mondays.